The angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism and the Adducin-1 (ADD1) G460W nonsense single nucleotide polymorphism (SNP) have previously been associated to hypertension, whereas their association with preeclampsia (PE) and gestational hypertension (GH) is still controversial. We genotyped ACE I/D, ADD1 G460W, and ADD1 S586C polymorphisms in 672 unrelated pregnant women: 204 PE (81/204 mild PE), 56 GH, and 412 controls, evaluating both their single and combined effects on these pathologies. The genotype combination of the 3 polymorphisms was not statistically different in cases versus controls, nor were ACE and ADD1 polymorphisms in GH. Nevertheless, the distribution of ACE genotypes was different in PE. This was confirmed in mild PE, whereas no significance was found in severe PE. This could suggest that different factors may lead to mild and severe PE, with ACE polymorphism playing a more important role in the mild form.
ACOG Committee onPractice Bulletins-Obstetrics.ACOG practice bulletin. Diagnosis and Management of Preeclampsia and Eclampsia. Obstet Gynecol. 2002;99(1): 159-167.
2.
Cooper DW, Liston WAGenetic control of severe preeclampsia. J Med Genet. 1979;16(6):409-416.
Cnattingius S., Reilly M., Pawitan Y., Lichtenstein P.Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet. 2004;130A(4):365-371.
5.
Salonen Ros H., Lichtenstein P., Lipworth L., Cnattingius S.Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet . 2000;91(4): 256-260.
6.
Medica I., Kastrin A., Peterlin B.Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis . Eur J Obstet Gynecol Reprod Biol. 2007;131(2):115-126.
7.
Lindheimer MDHypertension in pregnancy. Hypertension. 1993;22(1):127-137.
8.
Sutherland A. , Cooper DW, Howie PW, Liston WA, MacGillivray I.The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls. Br J Obstet Gynaecol. 1981;88(8):785-791.
9.
Khong TY, De Wolf F., Robertson WB, Brosens I.Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93(10):1049-1059.
10.
Aardema MW, Oosterhof H., Timmer A., van Rooy I., Aarnoudse JGUterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta. 2001;22(5):405-411.
11.
Griendling KK, Murphy TJ, Alexander RWMolecular biology of the renin angiotensin system. Circulation. 1993;87(6): 1816-1828.
12.
Broughton PFThe renin angiotensin system in normal and hypertensive pregnancy. In: Rubin PC, ed. Handbook of Hypertension. Amsterdam, Netherlands: Elsevier;1988:118-151.
13.
Shah DMThe role of RAS in the pathogenesis of preeclampsia. Curr Hypertens Rep. 2006;8(2):144-152.
14.
Herse F., Staff AC, Hering L., Müller DN, Luft FC, Dechend R.AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia . J Mol Med. 2008;86(6):697-703.
15.
Ehlers MRW , Riordan Jr.Angiotensin-converting enzyme. Biochemistry and molecular biology. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990:1217-1231.
16.
Soubrier F. , Hubert C., Testut P., Nadaud S., Alhenc-Gelas F., Corvol P.Molecular biology of the angiotensin I converting enzyme: biochemistry and structure of the gene. J Hypertens . 1993;11(5):471-476.
17.
Erdos EGAngiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension. 1990;16(4):363-370.
18.
Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F.An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-1346.
19.
Gürdöl F., Işbilen E., Yilmaz H., Isbir T., Dirican A.The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism. Clin Chim Acta. 2004;341(1-2):127-131.
20.
Mello G., Parretti E., Gensini F., et al. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension. 2003 ;41(4):932-937.
21.
Kaur R., Jain V., Khuller M., Gupta I., Sherawat BSAssociation of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension. Acta Obstet Gynecol Scand. 2005 ;84(10):929-933.
22.
Seremak-Mrozikiewicz A., Drews K., Chmara E., Mrozikiewicz A.Polymorphism of gene angiotensin converting enzyme in pregnancy induced hypertension. Ginekol Pol. 2001;72(8):605-610.
23.
Morgan L., Foster F., Hayman R., et al. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies. J Hypertens . 1999;17(6): 765-768.
24.
Heiskanen JT , Pirskanen MM, Hiltunen MJ, Mannermaa AJ, Punnonen KR, Heinonen STInsertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia. Am J Obstet Gynecol. 2001;185(3):600-603.
25.
Tamura T., Johanning GL, Goldenberg RL, Johnston KE, DuBard MBEffect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol. 1996;88(4 pt 1):497-502.
26.
Benedetto C. , Marozio L., Ciccone G., et al. Synergistic effect of renin-angiotensin system and nitric oxide synthase genes polymorphisms in pre-eclampsia. Acta Obstet Gynecol Scand. 2007;86(6):678-682.
27.
Kaiser HW, O’Keefe E., Bennett V.Adducin: Ca++ -dependent association with sites of cell-cell contact. J Cell Biol. 1989;109(2):557-569.
28.
Tripodi G., Valtorta F., Torielli L., et al. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest. 1996; 97(12):2815-2822.
29.
Mische SM, Mooseker MS, Morrow JSErythrocyte adducin: a calmodulin-regulated actin-bundling protein that stimulates spectrin-actin binding. J Cell Biol. 1987;105(6 pt 1): 2837-2845.
30.
Cusi D., Barlassina C., Azzani T., et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349(9062):1353-1357. Erratum in: Lancet. 1997;350:524.
31.
Glorioso N. , Manunta P., Filigheddu F., et al. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension. 1999;34(4Pt1):649-654.
32.
Staessen JA , Wang JG, Brand E., et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001;19(8):1349-1358. Erratum in: J Hypertens. 2001;19:1921.
33.
Brown MA, Lindheimer MD, de Swiet M., Van Assche A., Moutquin JMThe classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001 ;20(1):IX-XIV.
34.
Sibai BMDiagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-192.
35.
Parazzini F. , Cortinovis I., Bortolus R., Fedele L.Standard di peso alla nascita in Italia. Ann Ost Gin Med Perin. 1991; 112:203-246.
36.
Shanmugam V. , Sell KW, Saha BKMistyping ACE heterozygotes. PCR Methods Appl. 1993;3(2):120-121.
37.
Dunn OJMultiple comparisons among means. J Am Stat Assoc. 1961;56(293):52-64.
38.
Clark CJ, Davies E., Anderson NH, et al. Alpha-adducin and angiotensin I-converting enzyme polymorphisms in essential hypertension. Hypertension. 2000 ;36(6):990-994.
39.
Bianchi G., Ferrari P., Staessen JAAdducin polymorphism: detection and impact on hypertension and related disorders . Hypertension. 2005;45(3):331-340.
40.
Oudejans CB , van Dijk M., Oosterkamp M., Lachmeijer A., Blankenstein MAGenetics of preeclampsia: paradigm shifts . Hum Genet. 2007;120(5):607-612.
